BRCA1 and cancer: Example: Poly (ADP-ribose) polymerase inhibitors (PARPi) have shown efficacy in treating cancers with HR deficiencies, including those with mutations in the BRCA1 and BRCA2 genes, which are critical for homologous recombination (HR) repair.